New Federal Funding Will Increase Access to Substance Use Disorder Treatment
The Department of Health and Human Services (HHS) recently awarded funding to eleven states and numerous Federally Qualified Health Centers (FQHCs) to help increase patient access to substance use disorder (SUD) treatment services, focusing on treatment for opioid use disorders.
Funding administered through the Substance Abuse and Mental Health Services Administration (SAMHSA) will be available to states to expand the use of FDA approved medications in combination with evidence-based behavioral therapies—commonly referred to as Medication Assisted Treatment (MAT). SAMHSA is awarding up to $11 million annually in grants for three years to eleven states: Indiana, Iowa, Kentucky, Maryland, Massachusetts, Missouri, New Jersey, Vermont, Washington, Wisconsin, and Wyoming.
Additionally, the Health Resources and Services Administration (HRSA) will make $100 million in funding available to FQHCs to improve and expand the delivery of SUD services, focusing on MAT for opioid use.